Nolet Chris has filed 4 insider transactions across 2 companies since January 2024.
Most recent transaction: a grant/award of 7500 shares of Jasper Therapeutics, Inc. ($JSPR) on July 03, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 3, 2025 | Jasper Therapeutics, Inc. | $JSPR | Nolet Chris | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 15,333,962 | 9999.99% | 0.05% |
| June 18, 2025 | ArriVent BioPharma, Inc. | $AVBP | Nolet Chris | Director | A | Non-Qualified Stock Option (right to buy) | 15502 | $0.00 | 15,502.0000 | 33,898,870 | 9999.99% | 0.05% |
| June 6, 2024 | Jasper Therapeutics, Inc. | $JSPR | Nolet Chris | Director | A | Stock Option (right to buy) | 7500 | $0.00 | 7,500.0000 | 13,334,900 | 9999.99% | 0.06% |
| Jan. 25, 2024 | ArriVent BioPharma, Inc. | $AVBP | Nolet Chris | Director | A | Stock Option (right to buy) | 17884 | $0.00 | 17,884.0000 | 2,140,951 | 9999.99% | 0.84% |